AbbVie Inc (ABBV): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

AbbVie ( ABBV) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.2%. By the end of trading, AbbVie fell $0.58 (-1.1%) to $51.46 on average volume. Throughout the day, 5,844,923 shares of AbbVie exchanged hands as compared to its average daily volume of 7,022,900 shares. The stock ranged in price between $51.01-$52.50 after having opened the day at $52.25 as compared to the previous trading day's close of $52.04. Other companies within the Health Care sector that declined today were: NewLink Genetics ( NLNK), down 16.2%, Heat Biologics ( HTBX), down 11.5%, Baxano Surgical ( BAXS), down 11.4% and Synergetics USA ( SURG), down 11.2%.

AbbVie Inc., a research-based biopharmaceutical company, is engaged in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. AbbVie has a market cap of $82.1 billion and is part of the drugs industry. Shares are down 2.1% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate AbbVie a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates AbbVie as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and generally higher debt management risk.

On the positive front, Genocea Biosciences ( GNCA), up 23.3%, Ohr Pharmaceutical ( OHRP), up 22.0%, Agios Pharmaceuticals ( AGIO), up 13.8% and CEL-SCI Corporation ( CVM), up 11.9% , were all gainers within the health care sector with Jazz Pharmaceuticals ( JAZZ) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Stocks Rise as Bond Yields Inch Closer to 3% Threshold

Stocks Rise as Bond Yields Inch Closer to 3% Threshold

Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations

Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations

Trump to Blame for Oil's Recent Surge, Not OPEC

Trump to Blame for Oil's Recent Surge, Not OPEC

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

U.S. Earnings On Pace for Best Season in Two Decades but Tech Giants Await

U.S. Earnings On Pace for Best Season in Two Decades but Tech Giants Await